Murdoch D R, Curry C
Microbiology Unit, Canterbury Health Laboratories, Christchurch.
N Z Med J. 1998 May 8;111(1065):168-9.
To assess the incidence and impact of acute mountain sickness in the Southern Alps of New Zealand.
Over a 22 month period, mountaineers in the Mount Cook region were asked to complete a questionnaire at the completion of their climbing excursions. The questionnaire recorded demographic data and incorporated the Lake Louise scoring system to assess the presence of acute mountain sickness.
Of the 114 subjects who completed the questionnaire, 30 (26%) developed acute mountain sickness. The incidence was higher amongst those who slept above 2500 m (50%). Of those with acute mountain sickness, 33% reported that their symptoms resulted in no reduction in activity, while 13% reported a moderate or severe reduction in activity.
Mountaineers climbing in New Zealand's Southern Alps should be aware of the risk of acute mountain sickness, especially for those sleeping above 2500 m.
评估新西兰南阿尔卑斯山急性高山病的发病率及影响。
在22个月的时间里，库克山地区的登山者在攀登活动结束时被要求填写一份问卷。问卷记录了人口统计学数据，并采用路易斯湖评分系统来评估急性高山病的存在情况。
在完成问卷的114名受试者中，30人（26%）患上了急性高山病。在海拔2500米以上睡觉的人群中发病率更高（50%）。在患有急性高山病的人群中，33%报告称其症状并未导致活动量减少，而13%报告称活动量有中度或严重减少。
在新西兰南阿尔卑斯山登山的登山者应意识到急性高山病的风险，尤其是对于那些在海拔2500米以上睡觉的人。
